The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
How to achieve functional cure of HBV: Stopping NUCs, adding interferon or new drug development?
Open accessAbstract
Functional cure of hepatitis B is defined as sustained undetectable circulating HBsAg and HBV DNA after a finite course of treatment. Barriers to HBV cure include the reservoirs for HBV replication and antigen production (covalently closed circular DNA [cccDNA] and integrated HBV DNA), the high viral burden (HBV DNA and HBsAg) and the impaired host innate and adaptive immune responses against HBV. Current HBV therapeutics, 1 year of pegylated-interferon-α (PEG-IFNα) and long-term nucleos(t)ide analogues (NUCs), rarely achieve HBV cure. Stopping NUC therapy may lead to functional cure in some Caucasian patients but rarely in Asian patients. Switching from a NUC to IFN after HBV DNA suppression increases the chance of HBsAg clearance mainly in those with low HBsAg levels. Novel antiviral strategies that inhibit viral entry, translation and secretion of HBsAg, modulate capsid assembly, or target cccDNA transcription/degradation have shown promise in clinical trials. Novel immunomodulatory approaches including checkpoint inhibitors, metabolic modulation of T cells, therapeutic vaccines, adoptive transfer of genetically engineered T cells, and stimulation of innate and B-cell immune responses are being explored. These novel approaches may be further combined with NUCs or PEG-IFNα in personalised strategies, according to virologic and disease characteristics, to maximise the chance of HBV cure. The development of curative HBV therapies should be coupled with the development of standardised and validated virologic and immunologic assays to confirm target engagement and to assess response. In addition to efficacy, curative therapies must be safe and affordable to meet the goal of global elimination of hepatitis B.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schweitzer, A., Horn, J., Mikolajczyk, R. T., Krause, G., & Ott, J. J. (2015) · The Lancet · doi:10.1016/s0140-6736(15)61412-x · Cited by 2,742
Razavi-Shearer, D., Gamkrelidze, I., Nguyen, M. H., Chen, D.-S., Van Damme, P., Abbas, Z., Abdulla, M., Abou Rached, A., Adda, D., Aho, I., et al. (2018) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(18)30056-6 · Cited by 1,661
Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA
Lucifora, J., Xia, Y., Reisinger, F., Zhang, K., Stadler, D., Cheng, X., Sprinzl, M. F., Koppensteiner, H., Makowska, Z., Volz, T., et al. (2014) · Science · doi:10.1126/science.1243462 · Cited by 893
Rehermann, B., Ferrari, C., Pasquinelli, C., & Chisari, F. V. (1996) · Nature Medicine · doi:10.1038/nm1096-1104 · Cited by 854
Wooddell, C. I., Yuen, M.-F., Chan, H. L.-Y., Gish, R. G., Locarnini, S. A., Chavez, D., Ferrari, C., Given, B. D., Hamilton, J., Kanner, S. B., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aan0241 · Cited by 490
Adaptive immunity in HBV infection
Bertoletti, A., & Ferrari, C. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.026 · Cited by 483
Lanford, R. E., Guerra, B., Chavez, D., Giavedoni, L., Hodara, V. L., Brasky, K. M., Fosdick, A., Frey, C. R., Zheng, J., Wolfgang, G., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.003 · Cited by 377
Boni, C., Laccabue, D., Lampertico, P., Giuberti, T., Viganò, M., Schivazappa, S., Alfieri, A., Pesci, M., Gaeta, G. B., Brancaccio, G., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.014 · Cited by 377
The role of quantitative hepatitis B surface antigen revisited
Cornberg, M., Wong, V. W.-S., Locarnini, S., Brunetto, M., Janssen, H. L. A., & Chan, H. L.-Y. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.08.009 · Cited by 372
Cornberg, M., Lok, A. S.-F., Terrault, N. A., Zoulim, F., Berg, T., Brunetto, M. R., Buchholz, S., Buti, M., Chan, H. L. Y., Chang, K.-M., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.11.003 · Cited by 366
Self-citationEvens, A. M., Jovanovic, B. D., Su, Y., Raisch, D. W., Ganger, D. R., Belknap, S. M., Dai, M.-S., Chiu, B.-C. C., Fintel, B., Cheng, Y., et al. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq583 · Cited by 353
Hadziyannis, S. J., Sevastianos, V., Rapti, I., Vassilopoulos, D., & Hadziyannis, E. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.05.039 · Cited by 347
Gane, E., Verdon, D. J., Brooks, A. E., Gaggar, A., Nguyen, A. H., Subramanian, G. M., Schwabe, C., & Dunbar, P. R. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.06.028 · Cited by 345
Self-citationMarcellin, P., Ahn, S. H., Ma, X., Caruntu, F. A., Tak, W. Y., Elkashab, M., Chuang, W.-L., Lim, S.-G., Tabak, F., Mehta, R., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.09.043 · Cited by 342
Fisicaro, P., Barili, V., Montanini, B., Acerbi, G., Ferracin, M., Guerrieri, F., Salerno, D., Boni, C., Massari, M., Cavallo, M. C., et al. (2017) · Nature Medicine · doi:10.1038/nm.4275 · Cited by 341
Circulating and intrahepatic antiviral B cells are defective in hepatitis B
Burton, A. R., Pallett, L. J., McCoy, L. E., Suveizdyte, K., Amin, O. E., Swadling, L., Alberts, E., Davidson, B. R., Kennedy, P. T. F., Gill, U. S., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci121960 · Cited by 330
Yip, T. C.-F., Wong, G. L.-H., Chan, H. L.-Y., Tse, Y.-K., Lam, K. L.-Y., Lui, G. C.-Y., & Wong, V. W.-S. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.014 · Cited by 318
Self-citationFunctional skewing of the global CD8 T cell population in chronic hepatitis B virus infection
Das, A., Hoare, M., Davies, N., Lopes, A. R., Dunn, C., Kennedy, P. T. F., Alexander, G., Finney, H., Lawson, A., Plunkett, F. J., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072076 · Cited by 256
Qasim, W., Brunetto, M., Gehring, A. J., Xue, S.-A., Schurich, A., Khakpoor, A., Zhan, H., Ciccorossi, P., Gilmour, K., Cavallone, D., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.001 · Cited by 208
Rivino, L., Le Bert, N., Gill, U. S., Kunasegaran, K., Cheng, Y., Tan, D. Z. M., Becht, E., Hansi, N. K., Foster, G. R., Su, T.-H., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci92812 · Cited by 208
Janssen, H. L. A., Brunetto, M. R., Kim, Y. J., Ferrari, C., Massetto, B., Nguyen, A.-H., Joshi, A., Woo, J., Lau, A. H., Gaggar, A., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.10.027 · Cited by 203
Self-citationSchuch, A., Salimi Alizei, E., Heim, K., Wieland, D., Kiraithe, M. M., Kemming, J., Llewellyn-Lacey, S., Sogukpinar, Ö., Ni, Y., Urban, S., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-316641 · Cited by 180
Lok, A. S., Pan, C. Q., Han, S.-H. B., Trinh, H. N., Fessel, W. J., Rodell, T., Massetto, B., Lin, L., Gaggar, A., Subramanian, G. M., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.016 · Cited by 178
Self-citationCaviglia, G. P., Abate, M. L., Tandoi, F., Ciancio, A., Amoroso, A., Salizzoni, M., Saracco, G. M., Rizzetto, M., Romagnoli, R., & Smedile, A. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.021 · Cited by 177
Marcellin, P., Wong, D., Sievert, W., Buggisch, P., Petersen, J., Flisiak, R., Manns, M. P., Kaita, K., Krastev, Z., Lee, S. S., et al. (2019) · Liver International · doi:10.1111/liv.14155 · Cited by 175
Covalently closed circular DNA: The ultimate therapeutic target for curing HBV infections
Martinez, M. G., Boyd, A., Combe, E., Testoni, B., & Zoulim, F. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.05.013 · Cited by 165
Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B
Lebossé, F., Testoni, B., Fresquet, J., Facchetti, F., Galmozzi, E., Fournier, M., Hervieu, V., Berthillon, P., Berby, F., Bordes, I., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.12.024 · Cited by 164
Boni, C., Vecchi, A. L., Rossi, M., Laccabue, D., Giuberti, T., Alfieri, A., Lampertico, P., Grossi, G., Facchetti, F., Brunetto, M. R., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.01.030 · Cited by 157
Liem, K. S., Fung, S. K., Wong, D., Yim, C., Noureldin, S. A., Chen, J., Feld, J. J., Hansen, B. E., & Janssen, H. L. A. (2019) · Gut · doi:10.1136/gutjnl-2019-318981 · Cited by 153
Martinet, J., Dufeu‐Duchesne, T., Costa, J. B., Larrat, S., Marlu, A., Leroy, V., Plumas, J., & Aspord, C. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.08.046 · Cited by 141
Boni, C., Janssen, H. L. A., Rossi, M., Yoon, S. K., Vecchi, A. L., Barili, V., Yoshida, E. M., Trinh, H. N., Rodell, T. C., Laccabue, D., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.03.044 · Cited by 141
Boyd, A. C., Lacombe, K., Lavocat, F., Maylin, S., Miailhes, P., Lascoux‐Combe, C., Delaugerre, C., Girard, P., & Zoulim, F. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.014 · Cited by 128
García‐López, M., Lens, S., Pallett, L. J., Testoni, B., Rodríguez‐Tajes, S., Mariñó, Z., Bartrés, C., García‐Pras, E., Leonel, T., Perpiñán, E., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.11.043 · Cited by 107
APASL guidance on stopping nucleos(t)ide analogues in chronic hepatitis B patients
Kao, J., Jeng, W., Ning, Q., Su, T., Tseng, T., Ueno, Y., & Yuen, M. (2021) · Hepatology International · doi:10.1007/s12072-021-10223-5 · Cited by 106
Should Treatment Indications for Chronic Hepatitis B Be Expanded?
Jeng, W., & Lok, A. S.-F. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.04.091 · Cited by 84
Self-citationLiu, J., Wang, T., Zhang, W., Cheng, Y., He, Q., & Wang, F. (2020) · Hepatology International · doi:10.1007/s12072-020-10099-x · Cited by 76
Yuen, M., Zhou, X., Gane, E. J., Schwabe, C., Tanwandee, T., Feng, S., Jin, Y., Triyatni, M., Lemenuel‐Diot, A., Cosson, V. F., et al. (2021) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(21)00176-x · Cited by 70
Self-citationHBV Immune-Therapy: From Molecular Mechanisms to Clinical Applications
Boni, C., Barili, V., Acerbi, G., Rossi, M., Vecchi, A. L., Laccabue, D., Penna, A., Missale, G., Ferrari, C. I., & Fisicaro, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112754 · Cited by 63
Nishio, A., Bolte, F. J., Takeda, K., Park, N., Yu, Z., Park, H., Valdez, K., Ghany, M. G., & Rehermann, B. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aba6322 · Cited by 58
Hou, J., Ning, Q., Duan, Z., Chen, Y., Xie, Q., Wang, F., Zhang, L., Wu, S., Tang, H., Li, J., et al. (2021) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2020.00145 · Cited by 45
Kim, M. A., Kim, S. U., Sinn, D. H., Jang, J. W., Lim, Y., Ahn, S. H., Shim, J., Seo, Y. S., Baek, Y. H., Kim, S. G., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-320015 · Cited by 41
Ren, H., & Huang, Y. (2019) · Journal of Viral Hepatitis · doi:10.1111/jvh.13150 · Cited by 35
Chinnakannan, S. K., Cargill, T. N., Donnison, T. A., Ansari, M. A., Sebastian, S., Lee, L. N., Hutchings, C. L., Klenerman, P., Maini, M. K., Evans, T., et al. (2020) · Vaccines · doi:10.3390/vaccines8020184 · Cited by 34
Kosinska, A. D., Liu, J., Lu, M., & Roggendorf, M. (2014) · Medical Microbiology and Immunology · doi:10.1007/s00430-014-0379-5 · Cited by 33
Wong, G. L., Chan, H. L., Yuen, B. W., Tse, Y., Luk, H. W., Yip, T. C., Hui, V. W., Liang, L. Y., Lee, H. W., Lui, G. C.-Y., et al. (2019) · Liver International · doi:10.1111/liv.14330 · Cited by 24
Self-citationHadziyannis, E. S., & Hadziyannis, S. J. (2020) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2020.1738219 · Cited by 4
Cited by
Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics
Ma, X., Huang, T., Chen, X., Li, Q., Liao, M., Fu, L., Huang, J., Yuan, K., Wang, Z., & Zeng, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02104-8 · Cited by 133
Metadata
- Authors
- Wong, G. L. H., Gane, E., & Lok, A. S. F.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2022-06
- Volume
- 76
- Issue
- 6
- Pages
- 1249-1262
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W4280582189
- Cited by
- 272
- References
- 46
- FWCI
- 33.68
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.